Evidence map›Paper›PMID 41600926›Full record

ArticleVaccines2025

Compatibility and Stability of a

Poorva Taskar, Prashant Kumar, Brandy Dotson, Anup Datta, Shangdong Guo, Giriraj Chalke, Richa Puri, Harshita Seth, Benjamin Wizel, Sangeeta B Joshi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Poorva TaskarVaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, USA.ORCID 0009-0008-1314-0877
Prashant KumarVaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, USA.ORCID 0000-0002-4959-3156
Brandy DotsonVaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, USA.
Anup DattaInventprise Inc., Redmond, WA 98052, USA.ORCID 0000-0002-3796-6891
Shangdong GuoInventprise Inc., Redmond, WA 98052, USA.ORCID 0000-0002-5009-555X
Giriraj ChalkeInventprise Inc., Redmond, WA 98052, USA.
Richa PuriInventprise Inc., Redmond, WA 98052, USA.ORCID 0009-0000-2357-8356
Harshita SethInventprise Inc., Redmond, WA 98052, USA.ORCID 0009-0006-3054-0018
Benjamin WizelDynavax Technologies Corporation, 2929 Seventh Street, Suite 100, Berkeley, CA 94710, USA.ORCID 0000-0001-5212-867X
Sangeeta B JoshiVaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, USA.
David B VolkinVaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, USA.ORCID 0000-0002-1448-1998

Funding

Gates Foundation INV-037306Gates Foundation INV-038051
6 · The paper itself

Abstract

This study evaluated the formulation and stability of a quadrivalent glycoconjugate

Indexed as

adjuvantaluminum saltcompatibilityCpG 1018ELISAformulationpolysaccharide–protein conjugate vaccineShigella vaccinestability

Identifiers

PMID41600926
PMCPMC12846156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.